2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | - | - | - | 300 | 60.615 | 117.316 | 63.568 | 30.940 | - | - |
Total Income - EUR | - | - | - | 300 | 60.616 | 117.316 | 63.568 | 30.940 | - | - |
Total Expenses - EUR | - | - | - | 7.096 | 52.445 | 104.746 | 72.583 | 29.012 | - | - |
Gross Profit/Loss - EUR | - | - | - | -6.796 | 8.170 | 12.570 | -9.015 | 1.928 | - | - |
Net Profit/Loss - EUR | - | - | - | -6.798 | 6.355 | 10.362 | -10.651 | 999 | - | - |
Employees | - | - | - | 1 | 1 | 0 | 1 | 1 | - | - |
Check the financial reports for the company - Novastat Medical Srl
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | - | - | - | 5.430 | 20.929 | 45.338 | 26.962 | 15.909 | - | - |
Current Assets | - | - | - | 1.424 | 9.183 | 21.580 | 22.502 | 32.701 | - | - |
Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | - | - |
Receivables | - | - | - | 0 | 6.926 | 9.224 | 4.129 | 10.892 | - | - |
Cash | - | - | - | 1.424 | 2.257 | 12.356 | 18.373 | 21.809 | - | - |
Shareholders Funds | - | - | - | -6.755 | -265 | 10.102 | -740 | 276 | - | - |
Social Capital | - | - | - | 44 | 54 | 53 | 52 | 51 | - | - |
Debts | - | - | - | 13.609 | 30.377 | 59.423 | 54.054 | 48.334 | - | - |
Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | - | - |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "8622 - 8622" | |||||||||
CAEN Financial Year |
8622
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Novastat Medical Srl